NATCO PHARMA LIMITED (INDIA)
Cabazitaxel-kabanat
"Cabazitaxel" is the Drug / Molecule content in “Kabanat”. Cabazitaxel is a microtubule inhibitor.it binds to tubulin and promotesits assembly into microtubules while simultaneously inhibiting disassembly.This leads to the stabilization of microtubules,which result in the inhibition of mitotic andinterphase cellular functions.
Indication
"Kabanat" is a microtubule inhibitor indicated in combination with prednisone for the treatment of patients with hormone-refractory metastatic prostate cancer previously treated with a docetaxel containing treatment regimen.
Note
Precaution
- Kabanat is a prescription drug and should be used under proper medical guidance and advice.
- Avoid drinking grape fruit juice or eating grape fruit.
Strength
60 mg
Packing
Vial
Storage
Store at room Temperature (25 C).
Was this page helpful?
Related Products
Glenmark Pharmaceuticals Ltd.
Abirapro
CIPLA LTD.
Jevatax
Intas Pharmaceuticals Ltd (INDIA)
Bical
THERDOSE PHARMA PRIVATE LIMITED (INDIA)
Cabazither
Most Viewed Products
CIPLA LTD. (INDIA)
Abiraterone acetate-xbira
NATCO PHARMA LIMITED (INDIA)
Bendamustine-bendit
CIPLA LTD. (INDIA)
Bicalutamide-cassotide
NATCO PHARMA LIMITED (INDIA)
Bortezomib-bortenat
NATCO PHARMA LIMITED (INDIA)
Erlonat
Biocon Limited
Everolimus-evertor
NATCO PHARMA LIMITED (INDIA)
Exemestane-xtane
NATCO PHARMA LIMITED (INDIA)
Geftinat
NATCO PHARMA LIMITED (INDIA)
Glatiramer acetate-glatimer
NATCO PHARMA LIMITED (INDIA)
Ledipasvir & sofosbuvir-hepcinat lp
NATCO PHARMA LIMITED (INDIA)
Lenalidomide-lenalid
NATCO PHARMA LIMITED (INDIA)
Pomalidomide-pomalid
NATCO PHARMA LIMITED (INDIA)
Sofosbuvir & velpatasvir-velpanat
NATCO PHARMA LIMITED (INDIA)
Sorafenib-sorafenat
CIPLA LTD. (INDIA)